Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Yiyun Wang"'
Autor:
Han Liu, Yiyun Wang, Yingqiao Liu, Dingyi Lin, Cangui Zhang, Yuyun Zhao, Li Chen, Yi Li, Jianyu Yuan, Zhao Chen, Jiang Yu, Wentao Kong, Tao Chen
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveThe aim of this study is to identify prognostic imaging biomarkers and create a radiogenomics nomogram to predict overall survival (OS) in gastric cancer (GC).MaterialRNA sequencing data from 407 patients with GC and contrast-enhanced comput
Externí odkaz:
https://doaj.org/article/f3c3a32e3e1445afbb34bbcaf3dd036f
Autor:
Chenliang Zhou, Yiyun Wang, Zonghui Chen, Guowei Qian, Wenxi Yu, Yong Wang, Shuier Zheng, Zan Shen, Hongtao Li, Yonggang Wang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionTotally implanted ports (PORTs) have been widely used among patients with malignancy. Cardiac metastasis secondary to bone sarcoma and catheter-related right atrial thrombosis (CRAT) can be both present as cardiac masses. However, these t
Externí odkaz:
https://doaj.org/article/df6e591ecfd94aad84c13fc77d7a298d
Autor:
Jiuzhou Jiang, Hao Pan, Haomai Chen, Liyang Song, Yiyun Wang, Bao Qian, Pengfei Chen, Shunwu Fan, Xianfeng Lin
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Low back pain (LBP) is a common problem, but the efficacy of pharmacological therapies remains controversial. Therefore, we aimed to comprehensively evaluate and quantitatively rank various pharmacological therapies for patients with low back pain. T
Externí odkaz:
https://doaj.org/article/44f2d83836704e6fb5d8734db7801a3d
Autor:
Lijuan Ding, Yiyun Wang, Ruimin Hong, Houli Zhao, Linghui Zhou, Guoqing Wei, Wenjun Wu, Huijun Xu, Yanlei Zhang, Yi Luo, Jimin Shi, Alex H. Chang, Yongxian Hu, He Huang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Twenty patients with relapsed B-ALL after HSCT were treated with CAR T cell therapy and were evaluated for efficacy and safety. Twelve patients previously received haploidentical transplantation, while 8 patients received HLA-matched transplantation.
Externí odkaz:
https://doaj.org/article/ed99b4aebc0042c3818bc2e339dd62db
Autor:
Yiyun Wang, Linqin Wang, Yifan Zeng, Ruimin Hong, Cheng Zu, Elaine Tan Su Yin, Houli Zhao, Guoqing Wei, Li Yang, Aiyun Jin, Yongxian Hu, He Huang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Multiple myeloma (MM) with central nervous system (CNS) involvement is rare with only 1% incidence. So far, there is no standard or effective treatment for CNS MM, and the expected survival time is fewer than 6 months. Here, we report a case of MM wi
Externí odkaz:
https://doaj.org/article/cbd20a4390f643e0b766499414165902
Autor:
Yibei Dai, Yiyun Wang, Ying Cao, Pan Yu, Lingyu Zhang, Zhenping Liu, Ying Ping, Danhua Wang, Gong Zhang, Yiwen Sang, Xuchu Wang, Zhihua Tao
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
IntroductionProstate cancer (PCa) is one of the most frequently diagnosed cancers and the leading cause of cancer death in males worldwide. Although prostate-specific antigen (PSA) screening has considerably improved the detection of PCa, it has also
Externí odkaz:
https://doaj.org/article/09618bc4d7654c6f82daebeed0d607dc
Autor:
Ruimin Hong, Elaine Tan Su Yin, Linqin Wang, Xin Zhao, Linghui Zhou, Guangfa Wang, Mingming Zhang, Houli Zhao, Guoqing Wei, Yiyun Wang, Wenjun Wu, Yafei Zhang, Fang Ni, Yongxian Hu, He Huang, Kui Zhao
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Chimeric antigen receptor (CAR) T-cell therapy has exhibited promising clinical outcomes in treating relapsed/refractory (R/R) B-cell hematologic malignancies. Current studies have shown a close correlation between baseline tumor burden and therapeut
Externí odkaz:
https://doaj.org/article/60b213ea9f6b4e5aa3aa19508ffc66c9
Autor:
Linqin Wang, Ruimin Hong, Linghui Zhou, Fang Ni, Mingming Zhang, Houli Zhao, Wenjun Wu, Yiyun Wang, Shuyi Ding, Alex H. Chang, Yongxian Hu, He Huang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Although chimeric antigen receptor T (CAR-T) cell therapy has proven to be effective in treating relapsed or refractory B-cell hematological malignancies, severe hematological toxicities remain an intractable issue. This retrospective study assessed
Externí odkaz:
https://doaj.org/article/2836a8273dc64a76ba9de9ec484af9f9
Autor:
Yang Dong, Qunzi Zhang, Jiejun Wen, Teng Chen, Li He, Yiyun Wang, Jianyong Yin, Rui Wu, Rui Xue, Shiqi Li, Ying Fan, Niansong Wang
Publikováno v:
Frontiers in Physiology, Vol 10 (2019)
Ischemia reperfusion injury (IRI) is one of the most common causes of acute kidney injury (AKI). However, the pathogenesis and biomarkers predicting the progression of IRI-induced AKI to chronic kidney disease (CKD) remain unclear. A side-by-side com
Externí odkaz:
https://doaj.org/article/bbc5adbcc9814b9caa512187bac1b093
Autor:
Pan Yu, Xuchu Wang, Gong Zhang, Yibei Dai, Yiwen Sang, Ying Cao, Yiyun Wang, Zhihua Tao, Zhenping Liu, Lingyu Zhang, Danhua Wang, Ying Ping
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
IntroductionProstate cancer (PCa) is one of the most frequently diagnosed cancers and the leading cause of cancer death in males worldwide. Although prostate-specific antigen (PSA) screening has considerably improved the detection of PCa, it has also